Are you confused about why there is so much resistance to adopting the new FIGO endometrial staging? #EndometrialCancer MSKCC Team Uterus Here is my summary of the controversies in this topic gyoedu.org/publications-u…

Math at Halloween.

Whenever I come back to Visit Philly it’s the feeling of being back home !! Love this city!!

Everything, and I mean everything, is a function of time. Improvement only comes to what you invest your time in! Be mindful of where you spend it!!

Genetic Testing and PARP Inhibitors in Ovarian Cancer for OB/GYN residents

Publications Update # 85 gyoedu.org/publications-u…

Are you an OBGYN resident looking to learn basics of Gynecology Oncology. Consider the GYOEDU Resident Course: gyoedu.org/gyoedu-resident #obgyn #obgyndoctor #obgynresident #obgynresidency #resident #residency #surgery #gynecology #gynecologist #laboranddelivery

I encourage #GynOnc pros to take advantage of this opportunity to learn from the expertise of two of our field’s leaders.

So well deserved David Cohn, MD, MBA as the winner of distinguished service award at the SGO #sgomeeting2025

Basics of Gynecology Oncology Course for the residents - Now with quizzes #ObgynMatch gyoeducourses.org/basics-of-gyne…

Learn the basics of Gynecology Oncology to do well in your Gynecology Oncology Rotation gyoeducourses.org/basics-of-gyne… Now, with QUIZZES built into the lessons. #obgynresident #gynonc #match2025

#strangerthings night sky in ⁦Destination Ann Arbor⁩

Resident assessment quiz on GYOEDUCOURSES.org gyoedu.org/resident-asses… Give it a try! #match2025 #obgynresidents #gynonc

👩‍⚕️ Residents: jump-start your #GynOnc basics with our #BlackboardMethod—fast, chalk-style sessions that turn complex cases into clear takeaways. Start with this quick video on Non-Epithelial Ovarian Tumors and level up your learning ➡️ Visit courses.gyoedu.org for more

A new perspective on how to think about primary debulking surgery vs. neoadjuvant. Two articles discussed: Jochum F, Dumas É, Gougis P, et al. Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV

Hello Michigan! I’ll be in Ann Arbor next Thursday to discuss critical appraisal of cancer drug RCTs using the CSO checklist. Do drop by if you’re around (or by zoom). Perfect timing to get you all prepared for #ASCO25.

The most practice changing trial from #ASCO25 is now live on NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.

TRUST trial: In non-frail pts with stage IIIB-IVB ovarian cancer, PCS led to longer PFS (22.2 vs 19.7 mos, p=0.02) vs NACT/ICS. OS favored PCS (54.3 vs 48.3 mos, p=0.24), esp. in stage III pts (OS: 63.7 vs 53.2 mos). PCS remains standard in expert centers. #gyncsm #oncology Meshal

Most benefit in stage III pts (n=468): PCS vs NACT/ICS • PFS: 26.3 vs 21.4 mos • OS: 63.7 vs 53.2 mos Surgical quality mattered—complete resection = median OS of 67 mos. PCS offers long-term survival advantage in resectable, non-frail pts. #gyncsm #ovariancancer

Is it ok to cry when your patient progresses or has a recurrence? Is it ok to cry when facilitating end of life discussions? And how does that impact oncologist self perception and worth? Our poster in #ASCO2025 presented by amazing med student Hannah Catzen #burnout